quarta-feira, 7 de outubro de 2026
PesquisarExplore
pt.VIA.NEWS
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· January 13, 2026

Stocks Fall on Weakness in Software and Credit Card Companies

View original at nasdaq.com
Stocks Fall on Weakness in Software and Credit Card Companies The S&P 500 Index ($SPX) (SPY) on Tuesday closed down -0.19%, the Dow Jones Industrials Index ($DOWI) (DIA) closed down -0.80%, and the Nasdaq 100 Index ($IUXX) (QQQ) closed down -0.18%…
Opening lines of the source · short snapshot — read the full document at the original

O que extraímos desta fonte

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Justice Department was threatening a criminal indictment tied to his June testimony on Fed headquarters renovations

    80% confidence

  • Excluding the Magnificent Seven megacap technology stocks, Q4 earnings are expected to increase by +4.6%

    80% confidence

  • The vaccine schedule is not based on scientific evidence and will harm the public

    80% confidence

  • S&P earnings growth is expected to climb by +8.4% in Q4

    80% confidence

  • Option Care Health's forecast for 2026 EBITDA growth of +2% to +7% are better than expected

    80% confidence

  • It is unnecessary and unadvisable for the Fed to take an accommodative stance

    80% confidence

  • The US economy is pretty robust and he expects above-potential growth

    80% confidence

  • Credit-card lenders would be in violation of the law if they don't cap interest rates at 10% for one year

    80% confidence
O que sabemos · a inteligência por trás desta página
Ao vivo do substrato
O que estamos a ver
Obesity and Immunology Readouts, Big Pharma M&A and AI-Designed Drugs Converge Into a Q4 2026 Catalyst Wave
Late-stage data and deal activity are clustering ahead of Q4 2026. Novo Nordisk's CagriSema won Best Abstract at EASD 2026 for its brain and body (fMRI/MRI) data, Lilly showed ADtouch results for EBGLYSS and agreed to buy Merida Biosciences for $2.9B, and Merck's tulisokibart hit its Phase 2b endpoints. A key regulatory catalyst follows: the FDA PDUFA date for the ivonescimab BLA on 2026-11-14. AI-designed rentosertib showing anti-aging effects adds a speculative AI-drug-discovery thread, while QAIAx's microcities trial and QIII pilot (planned 2027-01-01) are peripheral, forecast-only items.
A nossa leitura dos dados ›
Sinais que acompanhamos
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Padrões que observamos ›
Onde as fontes divergem
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
Sinalizamos conflitos abertamente ›
Verificado recentemente
✓ Verificado com a fonte original
4,985
factos rastreados à sua fonte — e sinalizamos os que não se confirmam.
101 entidades acompanhadas4,985 factos verificados com a fonte5,351 documentos-fonte arquivados
Consulte estes dados → isubstrate.com
Stocks Fall on Weakness in Software and Credit Card Companies — Source | Via News | pt.VIA.NEWS